Steven Gannon

Insider Reports History

Entity
Individual
Location
C/O Xenon Pharmaceuticals Inc., 200 3650 Gilmore Way, Burnaby, Alberta, Canada
Signature
/s/ Nathaniel Adams, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Gannon:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Xenon Pharmaceuticals Inc. Director Common Shares 2K $92.4K $46.20 Mar 7, 2024 Direct
Xenon Pharmaceuticals Inc. Director Stock Option (Right to Buy) 15.5K Jun 5, 2024 Direct
Fusion Pharmaceuticals Inc. Director Common Stock 0 Jun 4, 2024 Direct
Fusion Pharmaceuticals Inc. Director Stock Option (Right to Buy) 0 Jun 4, 2024 Direct

Insider Reports Filed by Steven Gannon

Symbol Company Period Transactions Value $ Form Type Date Filed Role
XENE Xenon Pharmaceuticals Inc. Jun 5, 2024 1 $0 4 Jun 5, 2024 Director
FUSN Fusion Pharmaceuticals Inc. Jun 4, 2024 6 $0 4 Jun 4, 2024 Director
XENE Xenon Pharmaceuticals Inc. Mar 7, 2024 4 -$602K 4 Mar 8, 2024 Director
FUSN Fusion Pharmaceuticals Inc. Jun 14, 2023 1 $0 4 Jun 14, 2023 Director
XENE Xenon Pharmaceuticals Inc. Jun 2, 2023 1 $0 4 Jun 2, 2023 Director
FUSN Fusion Pharmaceuticals Inc. Aug 11, 2022 1 $90.1K 4 Aug 11, 2022 Director
XENE Xenon Pharmaceuticals Inc. Jun 28, 2022 1 $0 4 Jun 29, 2022 Director
FUSN Fusion Pharmaceuticals Inc. Jun 14, 2022 1 $0 4 Jun 22, 2022 Director
FUSN Fusion Pharmaceuticals Inc. Aug 23, 2021 1 $22.6K 4 Aug 23, 2021 Director
FUSN Fusion Pharmaceuticals Inc. Aug 18, 2021 2 $25.5K 4 Aug 20, 2021 Director
FUSN Fusion Pharmaceuticals Inc. Aug 16, 2021 1 $48.6K 4 Aug 17, 2021 Director
FUSN Fusion Pharmaceuticals Inc. Jun 4, 2021 1 $0 4 Jun 7, 2021 Director
XENE Xenon Pharmaceuticals Inc. Jun 3, 2021 1 $0 4 Jun 3, 2021 Director